Table 3 Univariate analysis for overall and disease-free survival
Overall Survival | Disease-Free Survival | |||
|---|---|---|---|---|
HR (95%CI) | p-value | HR (95%CI) | p-value | |
Age ≥ 55 vs < 55 years (ref.) | 0.58 (0.28–1.17) | 0.124 | 0.62 (0.35–1.12) | 0.109 |
Histological subtype other than squamous vs squamous (ref.) | 0.99 (0.35–2.78) | 0.988 | 0.82 (0.33–2.05) | 0.668 |
FIGO stage IIB-IVA vs IB2-IIA2 (ref.) | 3.54 (1.26–9.94) | 0.010 | 3.38 (1.45–7.88) | 0.003 |
Tumor size on imaging (cm) | 1.35 (1.11–1.64) | 0.003 | 1.27 (1.08–1.50) | 0.004 |
Tumor SUVmax | 1.07 (1.03–1.12) | 0.001 | 1.05 (1.01–1.09) | 0.012 |
Tumor MTV (/10 cc) | 1.10 (1.04–1.16) | < 0.001 | 1.07 (1.03–1.13) | 0.002 |
PLN SUVmax | 1.15 (1.05–1.26) | 0.002 | 1.12 (1.03–1.21) | 0.008 |
Number of PLN with uptake at FDG-PET/CT | 1.19 (1.07–1.33) | 0.002 | 1.17 (1.05–1.30) | 0.004 |